Researchers develop new method to 'fingerprint' HIV

March 28, 2017, The Scripps Research Institute
The researchers used their new method to create a map of the surface glycans on an HIV vaccine candidate glycoprotein. Credit: The Scripps Research Institute

HIV is a master of disguise. The virus uses a shield of sugar molecules, called glycans, to hide from the immune system and block antibodies from attacking it.

Now scientists at The Scripps Research Institute (TSRI) have developed a method to analyze the glycan shield on HIV's protective outer glycoprotein, developed as a potential HIV candidate.

With this method, scientists can rapidly create a "fingerprint" of the glycans on the glycoprotein to tell if they are on the right track in developing an effective vaccine.

"The ability to identify the glycan fingerprint on HIV's glycoprotein will help us develop a vaccine that matches what is found on the virus," said James Paulson, Cecil H. and Ida M. Green Chair of Chemistry at TSRI and co-chair of the Department of Molecular Medicine, who led the study published today in the journal Nature Communications.

Breaking Down HIV's Defenses

With the new method, scientists can finally see which types of glycans make up the glycoprotein—and whether the glycoprotein has any vulnerable holes.

The glycans cover the glycoprotein machinery that HIV uses to enter host cells. The human immune system wants to produce antibodies that bind to the glycoprotein to stop infection, but the glycans block immune cells from seeing their targets and developing useful antibodies.

At TSRI, several research teams are designing HIV vaccines that prompt the body to create rare "broadly neutralizing" antibodies that can actually get around the glycan, or sugar, shield. To do this, they need to introduce the immune system to HIV-like glycoproteins and teach the immune system where the holes in the glycan shield are.

For the new study, the researchers developed a way to figure out the composition of sugars on the glycoprotein. They used enzymes to break the glycoprotein into smaller peptide chunks. Next, the team used a technique called mass spectrometry to analyze these peptides and see if they fell into one of three categories: high-mannose glycans (a type with a specific kind of sugar), complex-type glycans (which are more mature glycans) or sites with no glycans.

While previous HIV studies had distinguished between high-mannose and complex-type , this was the first time scientists could also see the number of glycan-free sites. In fact, the new method has already revealed that the glycoprotein does not have as many holes as many researchers had predicted.

The new method also saves time. Previous studies using mass spectrometry had required researchers to manually analyze the peptide results—a process that could take months. By teaming up with the laboratory of TSRI Professor John Yates, the researchers in this study successfully used a computer algorithm to rapidly analyze results instead.

Study first author Liwei Cao, a research associate in the Paulson laboratory, said speed will come in handy as scientists sort through many HIV vaccine candidates to find the right ones to prevent a wide range of ever-evolving HIV strains.

The next step in this research is to analyze the glycan composition and glycan-free sites on the natural, or "native," form of HIV, not just an HIV-like vaccine candidate. "Then we can see if the fingerprints match up," Paulson said. If they do match, the researchers will know they are on a path to developing a vaccine that can induce useful antibodies.

This new method could also be helpful against viruses with a similar shield, such as influenza, Paulson explained. In fact, the new study included a side project where the researchers successfully tested their on an influenza protein.

Explore further: Scientists discover antibodies that target holes in HIV's defenses

More information: "Global site-specific N-glycosylation analysis of HIV envelope glycoprotein," Nature Communications, 2017.

Related Stories

Scientists discover antibodies that target holes in HIV's defenses

September 12, 2016
A new study from scientists at The Scripps Research Institute (TSRI) shows that "holes" in HIV's defensive sugar shield could be important in designing an HIV vaccine.

In pursuit of HIV vaccine, scientists shed light on antibody origins

December 15, 2015
From Peter Parker's fateful spider bite to Arthur pulling the sword from the stone at the beginning of his reign—everyone likes to know a hero's origin story.

Scientists show AIDS vaccine could work against changeable site on HIV

May 14, 2014
A vaccine or other therapy directed at a single site on a surface protein of HIV could in principle neutralize nearly all strains of the virus—thanks to the diversity of targets the site presents to the human immune system.

New TSRI study shows HIV structure in unprecedented detail

March 3, 2016
A new study from scientists at The Scripps Research Institute (TSRI) describes the high-resolution structure of the HIV protein responsible for recognition and infection of host cells.

Recommended for you

HIV exports viral protein in cellular packages

February 15, 2018
HIV may be able to affect cells it can't directly infect by packaging a key protein within the host's cellular mail and sending it out into the body, according to a new study out of a University of North Carolina Lineberger ...

Can gene therapy be harnessed to fight the AIDS virus?

February 13, 2018
For more than a decade, the strongest AIDS drugs could not fully control Matt Chappell's HIV infection. Now his body controls it by itself, and researchers are trying to perfect the gene editing that made this possible.

Big data methods applied to the fitness landscape of the HIV envelope protein

February 7, 2018
Despite significant advances in medicine, there is still no effective vaccine for the human immunodeficiency virus (HIV), although recent hope has emerged through the discovery of antibodies capable of neutralizing diverse ...

Scientists report big improvements in HIV vaccine production

February 5, 2018
Research on HIV over the past decade has led to many promising ideas for vaccines to prevent infection by the AIDS virus, but very few candidate vaccines have been tested in clinical trials. One reason for this is the technical ...

Microbiome research refines HIV risk for women

January 25, 2018
Drawing from data collected for years by AIDS researchers in six African nations, scientists have pinpointed seven bacterial species whose presence in high concentrations may significantly increase the risk of HIV infection ...

Researchers find latent HIV reservoirs inherently resistant to elimination by CD8+ T-cells

January 22, 2018
The latest "kick-and-kill" research to eliminate the HIV virus uncovered a potential obstacle in finding a cure. A recent study by researchers at the George Washington University (GW) found that latent HIV reservoirs show ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.